Domino's Pizza, Inc.

(New York Stock Exchange)
Back to all articles
Bearish -50

Sell alert! Why this expert is calling time on Domino's and Pro Medicus shares

AI-generated analysis

πŸ“‰ A leading analyst expects shares for Domino's Pizza Enterprises (DMP) and Pro Medicus (PME) to continue underperforming in the coming months.

πŸš€ Both stocks are trading higher today, with Domino's up 7.0% at $18.26 and Pro Medicus up 6.9% at $130.44, though this is a short-term anomaly.

πŸ˜“ Despite today's gains, Domino's shares remain down 29.5% year-to-date, while Pro Medicus shares are down 30.7%.

πŸ’° Current dividends paid by these ASX 200 companies have not compensated investors for the significant capital losses incurred over the past year.

⚠️ Michael Gable of Fairmont Equities maintains a negative outlook on the technology sector due to higher interest rates and market volatility.

πŸ” Gable specifically advises against Pro Medicus, citing that investors are questioning the high multiples of such tech companies during uncertain economic times.

πŸ“‰ A historical rotation from technology stocks toward hard assets like mining is expected to continue, according to analyst Michael Gable.

πŸ• Domino's faces potential margin pressure due to rising costs and declining consumer confidence, which could further suppress earnings.

⏳ No positive catalyst for Domino's is visible until the company releases its full-year results in August.

πŸ”„ Investors are likely to keep selling Domino's shares during any short-term market price bounces.

πŸ’¬ Fairmont Equities' Michael Gable does not see any emerging price support for Domino's at current levels.

πŸ”’ Michael Gable notes that technology stocks may require significant value depreciation before becoming attractive again to the market.

Bullish Signals
  • Both Domino's Pizza Enterprises Ltd (ASX: DMP) and Pro Medicus Ltd (ASX: PME) shares are trading higher today, with Domino's up 7.0% to $18.26 and Pro Medicus up 6.9% to $130.44.
  • Pro Medicus operates in the health imaging sector, providing medical imaging software and services to hospitals and healthcare groups across the world.
  • The ASX 200 Index is showing strong overall performance today, up 2.6%, indicating broad market confidence despite the specific sell recommendations from analysts.
Risk Factors
  • Domino's shares remain down 29.5% year-to-date, and Pro Medicus shares are down 30.7%, indicating significant ongoing capital loss for investors despite recent intraday gains.
  • Analyst Michael Gable from Fairmont Equities maintains a negative outlook on the technology sector due to higher interest rates, market volatility, and uncertainty surrounding high valuation multiples.
  • For Domino's, rising costs combined with lower consumer confidence are expected to erode margins and suppress earnings in the near term until full year results are released in August.
  • The fast food company faces a challenging period with no identified positive catalyst for price support at current levels, suggesting continued potential selling pressure on any market bounce.
  • Historical precedent suggests technology stocks like Pro Medicus could lose significant value before becoming attractive again, indicating further downside risk ahead of a sector rotation.
Full Analysis
A leading analyst from Fairmont Equities, Michael Gable, is recommending that investors consider selling shares in Domino's Pizza Enterprises Ltd and Pro Medicus Ltd despite a recent surge in their stock prices. On Wednesday, Domino's shares jumped 7.0% to trade at $18.26 apiece, while Pro Medicus shares rose 6.9% to reach $130.44, outpacing the broader ASX 200 Index which gained 2.6%. However, Gable argues that today's performance is not indicative of a longer-term trend and emphasizes that both companies remain down significantly from their valuations one year agoβ€”Domino's shares are down 29.5% since last year and Pro Medicus shares are down 30.7%. Gable expresses a negative outlook on the technology sector specifically regarding Pro Medicus, citing higher interest rates, market volatility, and investor uncertainty around high price multiples as key risks. He compares the current market dynamics to the early 2000s technology sell-off, suggesting that investors may continue rotating out of growth tech stocks into hard assets like mining companies. For Pro Medicus, which provides medical imaging software and services globally, he notes that these factors could lead to further capital losses before the stock becomes attractive again. Regarding Domino's, Gable warns that the fast-food giant is entering a challenging period where increasing costs and reduced consumer confidence could erode margins. He states there is no clear price support at current levels and identifies no positive catalysts until the company releases its full year results in August, expecting investors to continue selling on any short-term market bounces. The Motley Fool analyst Bernd Struben provides context to this recommendation while disclosing his background in economics and his history of analyzing global markets. It is noted that while both ASX 200 stocks are paying dividends, the payouts have not compensated shareholders for the substantial capital losses suffered over the past year. Additionally, a conflict of interest disclosure highlights that Motley Fool Holdings Inc. has positions in and has recommended both Domino's Pizza Enterprises and Pro Medicus, despite Struben himself having no position in either stock mentioned. The article concludes with a standard disclaimer regarding investment advice under AFSL 400691.